06978.HK
Immunotech Biopharm Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 0.40
+0.00%Aug 23, 2026, 14:06 UTC
Yongtai Biological (06978.HK) reported interim results for the six months ended June 2026, with other income of RMB 12.6 million, down 3.4% year-on-year, and a narrowed net loss of RMB 69.87 million from RMB 129 million a year earlier, with a loss per share of RMB 0.11, and no dividend declared.
Source: